Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03164291 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex
A Phase 3 study, sponsored by The University of Texas Health Science Center at Tyler.
- Completed
- Registry status
- Phase 3
- Development phase
- 170
- Enrollment target
NCT03164291: Completed Phase 3 study, sponsored by The University of Texas Health Science Center at Tyler.
NCT03164291 is a Phase 3 study that has completed, run by The University of Texas Health Science Center at Tyler. The registered enrollment target is 170 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03164291, a Phase 3 study, has completed, sponsored by The University of Texas Health Science Center at Tyler.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 170 participants
- Enrollment target
Study Summary
Treatment of adults with chronic Mycobacterium avium-intracellulare complex lung infections who have failed or are intolerant of rifampin. Rifabutin may be a reasonable alternative agent in patients who fail rifampin or or intolerant of rifampin.
Primary Outcome
neg cultures X3( sputum conversion)
Interventions
- DRUG Rifabutin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 1984-06 |
| Est. Completion | 2017-05-18 |
| Phase | Phase 3 |
What the finished NCT03164291 record still lists
NCT03164291 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Rifabutin is the first listed.
NCT03164291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03164291 about?
NCT03164291 is a clinical study titled "Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex". Treatment of adults with chronic Mycobacterium avium-intracellulare complex lung infections who have failed or are intolerant of rifampin. Rifabutin may be a reasonable alternative agent in patients who fail rifampin or or intolerant of rifampin.
What is the current status of trial NCT03164291?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 170 participants. The study started on 1984-06. Estimated completion is 2017-05-18.
What interventions are being tested in trial NCT03164291?
The interventions under investigation include: Rifabutin (DRUG).
Who is sponsoring clinical trial NCT03164291?
This trial is sponsored by The University of Texas Health Science Center at Tyler, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03164291's enrollment target sits among peer trials
170 1453rd of 2000 higher than 542 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia